Influence of cyclosporine on the occurrence of nephrotoxicity after allogeneic hematopoietic stem cell transplantation: a systematic review

Influence of cyclosporine on the occurrence of nephrotoxicity after allogeneic hematopoietic stem cell transplantation: a systematic review

Cyclosporine, a drug used in immunosuppression protocols for hematopoietic stem cell transplantation that has a narrow therapeutic index, may cause various adverse reactions, including nephrotoxicity. This has a direct clinical impact on the patient. This study aims to summarize available evidence i...

Full description

Bibliographic Details
Main Authors:	Juliana Bastoni da Silva, Maria Helena de Melo Lima, Sílvia Regina Secoli
Format:	Article
Language:	English
Published:	Elsevier 2014-10-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Subjects:	Stem cell transplantation Bone marrow transplantation Cyclosporine Acute kidney injury Toxicity
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842014000500363&lng=en&tlng=en

Similar Items

Multiple Eruptive Sebaceous Hyperplasia Secondary to Cyclosporin in a Patient with Bone Marrow Transplantation
by: Begonia Cortés, et al.
Published: (2016-11-01)

Difference in the Cytomegalovirus-related Clinical Laboratory Findings Between Patients With Bone Marrow and Kidney Transplantations
by: Misagh Rajabinejad, et al.
Published: (2021-08-01)

Electrolytes Disturbance and Cyclosporine Blood Levels among Kidney Transplant Recipients
by: B Einollahi, et al.
Published: (2012-10-01)

Intensive Observation of Toxic Side Effects After Several-Year of Cyclosporin Treatment in Kidney Transplant Patient
by: Mensura Ašćerić, et al.
Published: (2007-05-01)

Nephrotoxicity of Cyclosporine A and Amphotericin B-deoxycholate as continuous infusion in allogenic stem cell transplantation
by: K Furrer, et al.
Published: (2002-06-01)

Cyclosporine-induced reflex sympatethic dystrophy syndrome in a patient with graft versus host disease after bone marrow transplantation: a case report
by: Mortazavizadeh SMR, et al.
Published: (2009-04-01)

Factors associated with Cyclosporine A-induced gingival enlargement in kidney transplant patients
by: Javad Kia, et al.
Published: (2015-01-01)

Hepatic complications of allogeneic hematopoietic cell transplantation
by: Ramazan Idilman, et al.
Published: (2008-09-01)

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
by: Elena Kum, et al.
Published: (2021-01-01)

A Pediatric Patient with Intravenous Cyclosporine Anaphylaxis Who Tolerated the Oral Form
by: Pamir Işık, et al.
Published: (2014-12-01)

CYCLOSPORINE-INDUCED GINGIVAL OVERGROWTH IN RENAL TRANSPLANT RECIPIENTS
by: Ana Maria Filioreanu, et al.
Published: (2018-07-01)

Cyclosporine therapeutic window evaluation by Chebyshev's inequality method in kidney recipients
by: Aurelija Noreikaitė, et al.
Published: (2014-01-01)

Economic analysis of allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Center of Tunisia
by: Leila Achour, et al.
Published: (2023-12-01)

Cystoid macular edema after bone marrow transplantation
by: Khetan Vikas, et al.
Published: (2009-01-01)

Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan
by: Yi-Chang Lin, et al.
Published: (2019-09-01)

ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Federico Lussana, et al.
Published: (2014-10-01)

Successful repigmentation of vitiligo after allogeneic bone marrow transplantation for Hodgkin′s lymphoma by autologous noncultured melanocyte-keratinocyte transplantation
by: Huijuan Tang, et al.
Published: (2015-01-01)

Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine
by: P.G.P. Machado, et al.
Published: (2004-09-01)

A Survey of Infection in Allogenic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
by: S R Safayi, et al.
Published: (2018-08-01)

Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
by: Sahier O El-Khashab, et al.
Published: (2019-01-01)

Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation
by: G.A. Spinelli, et al.
Published: (2006-01-01)

Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients
by: Karel Krejci, et al.
Published: (2016-09-01)

Acute effect of nitroglycerin on cyclosporine-induced hypertension after cardiac transplantation
by: M Farshad, et al.
Published: (2010-03-01)

The effects of valsartan on renal glutathione peroxidase expression in alleviation of cyclosporine nephrotoxicity in rats
by: Sina Raeisi, et al.
Published: (2016-09-01)

Cyclosporine A nephropathy, its pathogenesis and management
by: Yusuf Erçin Sonmez
Published: (2021-12-01)

Prescribility of generic microemulsion Cyclosporine A in heart transplant patients Prescritibilidade de Ciclosporina A genérica microemulsão em transplantados cardíacos
by: Ricardo Manrique, et al.
Published: (2003-06-01)

The investigation of correlation between Iminoral concentration and neurotoxic levels after kidney transplantation
by: Zahra Tolou-Ghamari, et al.
Published: (2015-01-01)

Impact of donor marrow cellularity on outcome of allogeneic stem cell transplantation
by: Memoona Khan, et al.
Published: (2023-12-01)

Allogeneic Hematopoietic Stem Cell Transplantation After Prior Lung Transplantation for Hereditary Pulmonary Alveolar Proteinosis: A Case Report
by: Hanne Beeckmans, et al.
Published: (2022-07-01)

A COMPARATIVE ANALYSIS OF BIOEQUIVALENCE, CLINICAL EFFICACY AND SAFETY OF GENERIC VERSUS ORIGINAL CYCLOSPORINE AFTER KIDNEY TRANSPLANTATION
by: E. S. Stolyarevich, et al.
Published: (2015-04-01)

Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey
by: Gemma McErlean, et al.
Published: (2023-08-01)

Applications of flow cytometry to hematopoietic stem cell transplantation
by: Júlio C Voltarelli
Published: (2000-06-01)

Comparison of Doppler ultrasonographic indices before and after cyclosporine A peak serum level in stable kidney transplanted recipients
by: zohreh makki, et al.
Published: (2015-04-01)

Comparisons Between Allogeneic Peripheral Blood Stem Cell Transplantation and Allogeneic Bone Marrow Transplantation in Adult Hematologic Disease: A Single Center Experience
by: Yi-Chang Liu, et al.
Published: (2003-11-01)

Correlation between Cyclosporine Blood Levels and Area under Blood Concentration Time Curve in Iraqi Bone Marrow Transplant Patients Treated with Neoral<sup>®</sup> Oral Solution
by: Hassan M. Abass, et al.
Published: (2020-03-01)

The impact of epigenetic modifications on allogeneic hematopoietic stem cell transplantation
by: Yiouli P. Ktena, et al.
Published: (2023-05-01)

Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
by: Kyungmin Huh, et al.
Published: (2013-06-01)

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation
by: I. A. Lisukov, et al.
Published: (2014-07-01)

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation
by: I. A. Lisukov, et al.
Published: (2014-07-01)

The Relationship between the Plasma Level of Cyclosporine-A and Drug Dose in Patients of Kermanshah Kidney Transplantation Center
by: H Kharrazi, et al.
Published: (2005-07-01)